{"id":677,"date":"2016-07-18T15:49:16","date_gmt":"2016-07-18T13:49:16","guid":{"rendered":"http:\/\/aumed.cz\/en\/novinky\/"},"modified":"2024-11-11T14:39:30","modified_gmt":"2024-11-11T12:39:30","slug":"news","status":"publish","type":"page","link":"https:\/\/aumed.cz\/en\/news\/","title":{"rendered":"News"},"content":{"rendered":"

[vc_row full_width=”stretch_row” css=”.vc_custom_1469258305133{padding-top: 100px !important;padding-bottom: 0px !important;background-image: url(http:\/\/aumed.cz\/wp-content\/uploads\/2016\/06\/aumed_aktual.jpg?id=303) !important;}”][vc_column]

NEWS<\/h2><\/div>[vc_row_inner][vc_column_inner css=”.vc_custom_1469258300127{padding-top: 130px !important;}”]Aumed, a.s.<\/span><\/a><\/span><\/span>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1731328776951{padding-bottom: 50px !important;}”][vc_column el_class=”container”]
\n <\/div><\/div><\/div><\/div>
\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

New publication in Virology Journal summarizes the successes of Czech phage therapy and the significant role of AUMED, a.s.<\/h4><\/a>

14. 09. 2026<\/p>

A comprehensive review article summarizing the past, present, and future of phage therapy research and practice in the Czech Republic...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Our Research in the Media: Den\u00edk.cz on Our Work in Atopic Eczema<\/h4><\/a>

02. 06. 2026<\/p>

Read what they wrote about us. In a new article and an interview with our CEO, we discuss our research...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. Received Support for the Project “PhageBiome-N \u2013 Development of an innovative phage and probiotic formulation for the elimination of Staphylococcus aureus strains, including MRSA, and stabilization of the nasal microbiome for use in infection prevention and treatment.”<\/h4><\/a>

18. 12. 2025<\/p>

AUMED, a.s. is launching a project titled PhageBiome-N, which has received support under the Operational Programme Technologies and Applications for...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

A Century-Long Tradition of Czech Immunology and Vaccination: From the Institute of Sera and Vaccines (\u00daSOL) to AUMED, a.s.<\/h4><\/a>

11. 11. 2025<\/p>

The Beginnings and Establishment of the State Health Institute (SZ\u00da) AUMED, a.s. is the proud successor to an almost century-long...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. successfully participated in the immunology congress<\/h4><\/a>

29. 10. 2025<\/p>

AUMED representatives participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place from October...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. Received Support for the Project \u201cDevelopment of an Immunization Product for Protection Against the Causative Agent of Whooping Cough\u201d<\/h4><\/a>

08. 04. 2025<\/p>

AUMED has received support for the project titled \u201cDevelopment of an Immunization Product for Protection Against the Causative Agent of...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. has received support for the project “Innovation in the Production of Immunological Preparations”<\/h4><\/a>

07. 04. 2025<\/p>

AUMED has received support for the project “Innovation in the Production of Immunological Preparations,” registration number CZ.01.01.01\/02\/24_051\/0004982. The essence of...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED Pharma a.s., is expanding the Phage Glow range!<\/h4><\/a>

21. 03. 2025<\/p>

Our subsidiary, AUMED Pharma a.s., is expanding the Phage Glow range with two new product lines: ATOPCARE Atopcare is here...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. has received permission for a clinical trial, phase III, of the medicinal product TFI<\/h4><\/a>

16. 01. 2025<\/p>

Based on the submitted application and the supplied documents, the State Institute for Drug Control (Czech Republic) has authorized a...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. successfully completed a clinical trial, phase I, of the medicinal product TFI<\/h4><\/a>

16. 01. 2025<\/p>

AUMED, a.s. completed a clinical trial, phase I, of the medicinal product TFI (Transfer Factor) lyophilized mucoadhesive tablet for buccal-oral...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. presented current research at the 45th ICMM World Congress on Military Medicine<\/h4><\/a>

04. 10. 2024<\/p>

AUMED representatives participated in the 45th ICMM World Congress on Military Medicine held in Brisbane, Australia. At the congress, AUMED...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. presented phage research at the Viruses of Microbes 2024 conference in Cairns, Australia<\/h4><\/a>

04. 10. 2024<\/p>

AUMED representatives participated in the prestigious conference Viruses of Microbes 2024, which was held in the city of Cairns, Australia....<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Phage Glow Bioactive acne gel in new packaging<\/h4><\/a>

16. 07. 2024<\/p>

Now you can order Phage Glow Bioactive acne gel in a new package. This revolutionary beauty product based on phage...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Aumed Pharma a.s. launches the new Phage Glow Skin Spray<\/h4><\/a>

04. 06. 2024<\/p>

Our subsidiary Aumed Pharma a.s. launches a special bioactive gel intended for eczematous skin Phage Glow Skin Spray – a...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

New workplace BEN\u00c1TKY n\/J.<\/h4><\/a>

10. 05. 2024<\/p>

AUMED, a.s. at the beginning of 2024 opened a new workplace at the address 5. kv\u011btna 301, 294 71 Ben\u00e1tky...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Aumed Pharma a.s. launches new food supplement Gut Guard<\/h4><\/a>

07. 03. 2024<\/p>

Our subsidiary Aumed Pharma a.s. launches food supplement Gut Guard. Gut Guard probiotics contain a combination of 13 vital probiotic...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. received support for the development of a preparation with phages for recurrent bacterial vaginosis<\/h4><\/a>

06. 03. 2024<\/p>

AUMED received support for the project “Development of an antibacterial preparation with phages for recurrent bacterial vaginosis”, registration number CZ.01.01.01\/01\/22_002\/0000523....<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. received support for the development of a vaccine against Staphylococcus aureus<\/h4><\/a>

18. 12. 2023<\/p>

AUMED received support for the project “Development of a new vaccine against Staphylococcus aureus”, registration number CZ.01.01.01\/01\/22_002\/0000585. Staphylococcus aureus causes...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. received support for the development of a product for the supportive treatment of the skin in the case of atopic eczema<\/h4><\/a>

18. 12. 2023<\/p>

AUMED received support for the project “Development of a preparation based on a cleansing spray intended for the supportive treatment...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED participated in the immunology congress with great success<\/h4><\/a>

14. 11. 2023<\/p>

Representatives of AUMED participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place in...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. successfully completed the project “Comparison of the effectiveness of three different batches of leukocyte extract with transfer factor activity (TFI) in the form of fast-dissolving tablets”<\/h4><\/a>

02. 11. 2023<\/p>

AUMED, a.s. successfully completed the project “Comparison of the effectiveness of three different batches of leukocyte extract with transfer factor...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

A revolution in the fight against problematic skin<\/h4><\/a>

29. 08. 2023<\/p>

Our subsidiary Aumed Pharma a.s. is launching a revolutionary bacteriophage-based product in the fight against problematic skin. Phage Glow is...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

The new website of our subsidiary Aumed Pharma a.s.<\/h4><\/a>

29. 08. 2023<\/p>

Our subsidiary Aumed Pharma is launching a new website (www.aumedpharma.cz) where you can purchase our specially developed nutritional supplements and...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED joins the association fighting against antibiotic resistance<\/h4><\/a>

18. 07. 2023<\/p>

A representative of AUMED participated in the meeting to establish the association Czech Antibiotic Resistance Platform (CZEPAR). The course of...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. successfully completed the project entitled “Transfer factor TFI – Medicinal product”<\/h4><\/a>

28. 06. 2023<\/p>

AUMED, a.s. successfully completed the project entitled “Transferfaktor TFI – Medicinal product”, registration number CZ.01.1.02\/0.0\/0.0\/20_318\/0026008. As part of the project,...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”<\/h4><\/a>

29. 11. 2022<\/p>

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”, registration number CZ.01.1.02\/0.0\/0.0\/20_318\/0026008. As...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. presented phage research at the Phages 2022 conference in Oxford<\/h4><\/a>

26. 09. 2022<\/p>

AUMED participated in the 12th annual bacteriophage conference in Oxford, which is the only European phage conference with such a...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED a.s. founded a new company AUMED Immunology a.s.<\/h4><\/a>

19. 09. 2022<\/p>

AUMED a.s. founded a new company AUMED Immunology a.s.. AUMED, a.s. is the sole shareholder of the newly formed company....<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Successful completion of the TRIO project \u201eDevelopment of a new dosage form for oral vaccine administration\u201d<\/h4><\/a>

18. 05. 2022<\/p>

AUMED, a.s. successfully completed a multi-year project of the research and development support program of the Ministry of Industry and...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED, a.s. received a grant for the Innovation Project entitled “TFI Transfer Factor – Medicine”<\/h4><\/a>

18. 05. 2022<\/p>

AUMED, a.s. received a grant in the Operational Program Enterprise and Innovation for Competitiveness under the Innovation Call – Innovation...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

PCR GARGLING KIT<\/h4><\/a>

07. 05. 2021<\/p>

AUMED, a.s. launches its own self-sampling set based on the principle of gargling of the oral cavity and pharynx. The...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

AUMED a.s. received support for the production of a diagnostic kit for covid-19<\/h4><\/a>

13. 12. 2020<\/p>

AUMED a.s. received support for the project PRODUCTION OF DIAGNOSTIC KIT FOR COVID-19 ON THE LAMP PRINCIPLE within the TECHNOLOGY...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

New sampling set GARGTEST<\/h4><\/a>

30. 11. 2020<\/p>

AUMED, a.s. collaborated on the development of a new self-sampling set based on the principle of gargling of the oral...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

\u201cCOVID-19\u201d TESTING FOR COMPANIES<\/h4><\/a>

22. 10. 2020<\/p>

AUMED a.s. offers for companies a comprehensive solution for preventive testing of the SARS-CoV-2 virus (COVID-19). We provide sampling and...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Covid-19 diagnostics using a newly developed test – AUMED test RT-LAMP Assay SARS-CoV-2<\/h4><\/a>

01. 10. 2020<\/p>

AUMED a.s. is involved in the fight against the Covid-19 pandemic. In cooperation with Protean s.r.o.\u00a0and Institute of Molecular and...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Successful completion of the OPPIK project ” Transfer factor – research and development of a new dosage form of immunotherapeutic medicinal product “<\/h4><\/a>

31. 08. 2020<\/p>

This year, company AUMED a.s. successfully completed a multi-year project of the OPPIK program entitled “Transfer factor – research and...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Successful completion of the OPPIK project “RESEARCH AND DEVELOPMENT OF A NEW WHOLE-CELL VACCINE AGAINST WHOOPING COUGH”<\/h4><\/a>

31. 08. 2020<\/p>

This year, company AUMED a.s. successfully completed a multi-year project of the OPPIK program entitled “RESEARCH AND DEVELOPMENT OF A...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Achievements in current grants<\/h4><\/a>

02. 12. 2019<\/p>

The project of innovative vaccine against whooping cough is in the terminal phase. The priority is the research and development...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Pharmaceutical production<\/h4><\/a>

12. 11. 2019<\/p>

AUMED is preparing the production of a mass-produced medical product. Under the contract manufacturing regime, AUMED wants to become a...<\/p> <\/div><\/div>

\"\"
FULL ARTICLE<\/div><\/div><\/a><\/div><\/div>

Research and development of a new oral administration of the vaccine in the company AUMED, a.s.<\/h4><\/a>

21. 10. 2019<\/p>

As part of the 4th public tender in the TRIO program, AUMED has a project for a new version of...<\/p> <\/div><\/div><\/div><\/div><\/div>